Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Holist Nurs ; 42(1): 64-78, 2024 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-37128683

RESUMO

Purpose: To evaluate effectiveness of chairside yoga therapy on perceptions of fatigue, pain, nausea, anxiety, and distress among oncology patients concurrently receiving outpatient cancer infusion therapy. Design: This prospective pilot study used pre-/post-survey design in convenience sample of cancer patients in outpatient setting. Methods: Researchers developed and administered the Outpatient Cancer Symptom Assessment Scale (OCSAS) comprised of cancer- or treatment-related symptoms commonly reported in the oncology population (nausea, pain, fatigue, anxiety, and distress). Following IRB approval, symptoms were rated using Likert scale of 0 (not present) to 10 (severe) before and after chairside yoga therapy delivered concurrently with outpatient infusions. Qualitative data was collected related to patients' overall infusion experience. Findings: Participants (n = 82) reported positive patient experiences and statistically less pain (p < 0.001), fatigue (p < 0.001), anxiety (p < 0.001), and distress (p < 0.001) following the yoga intervention compared to baseline. Nausea was not significantly impacted by the yoga intervention. Conclusions: Yoga therapy received concurrently during outpatient cancer infusion is consistent with a holistic and integrative approach to care for the oncology population. Yoga therapy offers promise for reducing symptoms which negatively impact quality of life, including pain, fatigue, anxiety, and distress. Qualitative data suggests patients' overall infusion experience was enhanced with yoga therapy.


Assuntos
Neoplasias , Yoga , Humanos , Pacientes Ambulatoriais , Qualidade de Vida , Estudos de Viabilidade , Projetos Piloto , Estudos Prospectivos , Depressão/terapia , Ansiedade/terapia , Neoplasias/complicações , Neoplasias/terapia , Dor , Fadiga/etiologia , Fadiga/terapia , Náusea
2.
Ugeskr Laeger ; 169(42): 3562-6, 2007 Oct 15.
Artigo em Dinamarquês | MEDLINE | ID: mdl-18031666

RESUMO

Obesity is increasing globally. Lifestyle and genetic factors alone cannot explain this increase. This review study describes possible associations between environmental chemicals and the growing prevalence of obesity. The review mainly focuses on halogenated organic compounds and their possible effect on obesity development. The literature is, however, limited and knowledge of the mechanisms insufficient. Consequently, it is difficult to describe the risks from these chemicals on obesity development.


Assuntos
Disruptores Endócrinos/efeitos adversos , Poluentes Ambientais/efeitos adversos , Obesidade/etiologia , Adipócitos/efeitos dos fármacos , Animais , Diferenciação Celular/efeitos dos fármacos , Surtos de Doenças , Desenvolvimento Embrionário/efeitos dos fármacos , Disruptores Endócrinos/toxicidade , Poluentes Ambientais/toxicidade , Humanos , Hidrocarbonetos Bromados/efeitos adversos , Hidrocarbonetos Bromados/toxicidade , Hidrocarbonetos Halogenados/efeitos adversos , Hidrocarbonetos Halogenados/toxicidade , Obesidade/epidemiologia , Prevalência , Fatores de Risco , Aumento de Peso/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...